Sign In
Buy BRKR
$62.70
+5.39 (+9.40%)
At Close: Jun 03, 2026
Here's Why You Should Add Bruker (BRKR) Stock to Your Kitty
01:52pm, Monday, 04'th Apr 2022 Zacks Investment Research
Bruker's (BRKR) Nano Group microelectronics and semiconductor metrology tools continue to perform well on ongoing strength in bookings and backlog.
Here's Why You Should Add Bruker (BRKR) Stock to Your Kitty
11:18am, Monday, 04'th Apr 2022
Bruker's (BRKR) Nano Group microelectronics and semiconductor metrology tools continue to perform well on ongoing strength in bookings and backlog.
Does Bruker (BRKR) Have the Potential to Rally 33% as Wall Street Analysts Expect?
03:00pm, Monday, 07'th Mar 2022 Zacks Investment Research
The consensus price target hints at a 33.5% upside potential for Bruker (BRKR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r
Does Bruker (BRKR) Have the Potential to Rally 33% as Wall Street Analysts Expect?
11:15am, Monday, 07'th Mar 2022
The consensus price target hints at a 33.5% upside potential for Bruker (BRKR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r
Bruker (BRKR) to Improve Spatial Biology With New Launch
03:02pm, Friday, 04'th Mar 2022 Zacks Investment Research
Bruker's (BRKR) acquired company, Canopy Biosciences, introduced its next generation of ChipCytometry instrumentation for spatial biology.
Canopy Biosciences launches CellSpace system for use in tissue analysis
01:07pm, Friday, 04'th Mar 2022 Seeking Alpha
Biotech company Canopy Biosciences (BRKR) on Friday announced the launch of its Chip Cytometry instrument called CellSpace system. ChipCytometry delivers single-cell targeted…
Bruker (BRKR) to Improve Spatial Biology With New Launch
11:32am, Friday, 04'th Mar 2022
Bruker's (BRKR) acquired company, Canopy Biosciences, introduced its next generation of ChipCytometry instrumentation for spatial biology.
Bruker (BRKR), Newomics to Co-Market Joint MnESI-MS Platform
02:18pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
The maxis II and timsTOF Pro 2 mass spectrometers from Bruker (BRKR) will be marketed with Newomics's MnESI product line.
Here's Why You Should Invest In Bruker (BRKR) Stock Now
02:17pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Investors are optimistic about Bruker's (BRKR) better-than-expected revenues and robust segmental performance.
Here's Why You Should Invest In Bruker (BRKR) Stock Now
10:44am, Tuesday, 01'st Mar 2022
Investors are optimistic about Bruker's (BRKR) better-than-expected revenues and robust segmental performance.
Here's How Much a $1000 Investment in Bruker Made 10 Years Ago Would Be Worth Today
01:30pm, Monday, 28'th Feb 2022 Zacks Investment Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Bruker Corporation to Present at Cowen's 42nd Annual Health Care Conference
07:00am, Monday, 28'th Feb 2022
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in Cowen's 42nd Annual Health Care Conference which is taking place virtually o
For Big Money, Bruker Corporation Passes Test
12:32pm, Tuesday, 22'nd Feb 2022 FX Empire
Bruker Corporation (BRKR) stock has jumped over the past month, gaining 3.6%. And the scientific instrument company could rise even more due to growing demand. But another likely reason is Big Money lifting the stock.
Bruker raises dividend by 25% to $0.05/share
12:16pm, Friday, 18'th Feb 2022 Seeking Alpha
Bruker (BRKR) declares $0.05/share quarterly dividend, 25% increase from prior dividend of $0.04.
Wall Street Analysts See a 31% Upside in Bruker (BRKR): Can the Stock Really Move This High?
03:00pm, Thursday, 17'th Feb 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 31.4% in Bruker (BRKR). While the effectiveness of this highly sought-after metric is questionable, the positiv
